Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-007324

Options or other derivatives

  • Director acquired 94,441 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
HILZINGER KURT J Director 2024-03-07 Grant or award · Stock Option (Right to Buy) +94,441 94,441 D: show line 1 in the form
Loading xslF345X05/form4-03082024_090353.xml…